FDA Wants to Ban Another Natural Supplement with Success in Treating Symptoms of COVID-19

N-acetyl-L-cysteine (NAC) has been on the market as a supplement for decades—why is the FDA attacking it now? It seems obvious that the FDA is clearing the market of affordable NAC supplements in an effort to eliminate competition for NAC drugs that could be coming to market in the next few years. For starters, a drug company is investigating NAC as a treatment for a rare genetic disorder that damages the myelin sheath, which insulates nerve cells in the brain. But that’s just the beginning. A search through the government’s clinical trials database shows considerable interest from the pharmaceutical industry in NAC. There are 17 trials looking at NAC, in both drug and supplement form, in the treatment of COVID.